These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 35204744)

  • 1. Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson's Disease.
    Chagraoui A; Di Giovanni G; De Deurwaerdère P
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
    Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
    Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia.
    Lanza K; Centner A; Coyle M; Del Priore I; Manfredsson FP; Bishop C
    Exp Neurol; 2021 Feb; 336():113534. PubMed ID: 33249031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.
    Solís O; Garcia-Montes JR; González-Granillo A; Xu M; Moratalla R
    Cereb Cortex; 2017 Jan; 27(1):435-446. PubMed ID: 26483399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction.
    Fanni S; Scheggi S; Rossi F; Tronci E; Traccis F; Stancampiano R; De Montis MG; Devoto P; Gambarana C; Bortolato M; Frau R; Carta M
    Neurobiol Dis; 2019 Jan; 121():120-130. PubMed ID: 30261284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptors: homomeric and heteromeric complexes in L-DOPA-induced dyskinesia.
    Solís O; Moratalla R
    J Neural Transm (Vienna); 2018 Aug; 125(8):1187-1194. PubMed ID: 29417335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2.
    Bono F; Tomasoni Z; Mutti V; Sbrini G; Kumar R; Longhena F; Fiorentini C; Missale C
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological targeting of G protein-coupled receptor heteromers.
    Moreno E; Casajuana-Martin N; Coyle M; Campos BC; Galaj E; Del Torrent CL; Seyedian A; Rea W; Cai NS; Bonifazi A; Florán B; Xi ZX; Guitart X; Casadó V; Newman AH; Bishop C; Pardo L; Ferré S
    Pharmacol Res; 2022 Nov; 185():106476. PubMed ID: 36182040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects.
    Albarrán-Bravo S; Ávalos-Fuentes JA; Cortés H; Rodriguez-Sánchez M; Leyva-García N; Rangel-Barajas C; Erlij D; Florán B
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors.
    Cote SR; Chitravanshi VC; Bleickardt C; Sapru HN; Kuzhikandathil EV
    Behav Brain Res; 2014 Apr; 263():46-50. PubMed ID: 24462727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [L-dopa induced dyskinesia in Parkinson's disease].
    Bastide MF; Bézard E
    Bull Acad Natl Med; 2015; 199(2-3):201-12. PubMed ID: 27476302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of hydroxysafflor yellow A with levodopa attenuates the dyskinesia.
    Wang T; Duan SJ; Wang SY; Lu Y; Zhu Q; Wang LJ; Han B
    Physiol Behav; 2015 Aug; 147():193-7. PubMed ID: 25914172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The D3 dopamine receptor: From structural interactions to function.
    Fiorentini C; Savoia P; Bono F; Tallarico P; Missale C
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1462-9. PubMed ID: 25532864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history.
    Shan L; Diaz O; Zhang Y; Ladenheim B; Cadet JL; Chiang YH; Olson L; Hoffer BJ; Bäckman CM
    Brain Res; 2015 Aug; 1618():261-9. PubMed ID: 26086365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats.
    Kiessling CY; Lanza K; Feinberg E; Bishop C
    Neuropharmacology; 2020 Sep; 174():108138. PubMed ID: 32492451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor-Receptor Interaction and Striatal Function.
    Bono F; Mutti V; Tomasoni Z; Sbrini G; Missale C; Fiorentini C
    Curr Top Behav Neurosci; 2023; 60():47-72. PubMed ID: 35505059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats.
    Sgroi S; Capper-Loup C; Paganetti P; Kaelin-Lang A
    Exp Neurol; 2016 Jun; 280():80-8. PubMed ID: 27072528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
    Lindenbach D; Dupre KB; Eskow Jaunarajs KL; Ostock CY; Goldenberg AA; Bishop C
    Brain Res; 2013 Nov; 1537():327-39. PubMed ID: 24060645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.